CN103751702A - Breast cancer treatment traditional Chinese medicine - Google Patents
Breast cancer treatment traditional Chinese medicine Download PDFInfo
- Publication number
- CN103751702A CN103751702A CN201310677013.8A CN201310677013A CN103751702A CN 103751702 A CN103751702 A CN 103751702A CN 201310677013 A CN201310677013 A CN 201310677013A CN 103751702 A CN103751702 A CN 103751702A
- Authority
- CN
- China
- Prior art keywords
- grams
- radix
- chinese medicine
- traditional chinese
- breast cancer
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 206010006187 Breast cancer Diseases 0.000 title claims abstract description 37
- 239000003814 drug Substances 0.000 title claims abstract description 32
- 235000003140 Panax quinquefolius Nutrition 0.000 claims abstract description 5
- 235000008434 ginseng Nutrition 0.000 claims abstract description 5
- 235000005035 ginseng Nutrition 0.000 claims abstract description 5
- 240000002123 Curcuma aromatica Species 0.000 claims abstract description 4
- 240000001816 Prunella vulgaris Species 0.000 claims abstract description 4
- 239000002994 raw material Substances 0.000 claims abstract description 4
- 240000004678 Panax pseudoginseng Species 0.000 claims abstract 2
- 201000008275 breast carcinoma Diseases 0.000 claims description 28
- 241000545442 Radix Species 0.000 claims description 9
- 241000255791 Bombyx Species 0.000 claims description 4
- 241000283956 Manis Species 0.000 claims description 4
- 241000722953 Akebia Species 0.000 claims description 3
- 235000014375 Curcuma Nutrition 0.000 claims description 3
- 241001523579 Ostrea Species 0.000 claims description 3
- 241001180876 Saposhnikovia Species 0.000 claims description 3
- 241000207929 Scutellaria Species 0.000 claims description 3
- 210000004185 Liver Anatomy 0.000 abstract description 15
- 210000000952 Spleen Anatomy 0.000 abstract description 13
- 210000004369 Blood Anatomy 0.000 abstract description 12
- 239000008280 blood Substances 0.000 abstract description 12
- 229940079593 drugs Drugs 0.000 abstract description 9
- 230000000694 effects Effects 0.000 abstract description 9
- 201000011510 cancer Diseases 0.000 abstract description 7
- 238000005728 strengthening Methods 0.000 abstract description 5
- 238000002512 chemotherapy Methods 0.000 abstract description 4
- 206010027476 Metastasis Diseases 0.000 abstract description 2
- 240000001992 Angelica archangelica Species 0.000 abstract 2
- 241000675108 Citrus tangerina Species 0.000 abstract 2
- 235000001287 Guettarda speciosa Nutrition 0.000 abstract 2
- 241001061264 Astragalus Species 0.000 abstract 1
- 235000010110 Astragalus glycyphyllos Nutrition 0.000 abstract 1
- 241000255789 Bombyx mori Species 0.000 abstract 1
- 241000510654 Bupleurum chinense Species 0.000 abstract 1
- 235000003398 Curcuma aromatica Nutrition 0.000 abstract 1
- 240000005389 Glycyrrhiza glabra Species 0.000 abstract 1
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 abstract 1
- 235000017443 Hedysarum boreale Nutrition 0.000 abstract 1
- 235000007858 Hedysarum occidentale Nutrition 0.000 abstract 1
- 241000212322 Levisticum officinale Species 0.000 abstract 1
- 241000146029 Lindera aggregata Species 0.000 abstract 1
- 241001673966 Magnolia officinalis Species 0.000 abstract 1
- 241000237502 Ostreidae Species 0.000 abstract 1
- 240000004600 Paeonia lactiflora Species 0.000 abstract 1
- 235000008598 Paeonia lactiflora Nutrition 0.000 abstract 1
- 241000283966 Pholidota <mammal> Species 0.000 abstract 1
- 235000006753 Platycodon grandiflorum Nutrition 0.000 abstract 1
- 240000003582 Platycodon grandiflorus Species 0.000 abstract 1
- 241001180873 Saposhnikovia divaricata Species 0.000 abstract 1
- 240000004534 Scutellaria baicalensis Species 0.000 abstract 1
- 235000017089 Scutellaria baicalensis Nutrition 0.000 abstract 1
- 240000001949 Taraxacum officinale Species 0.000 abstract 1
- 240000006023 Trichosanthes kirilowii Species 0.000 abstract 1
- 235000009818 Trichosanthes kirilowii Nutrition 0.000 abstract 1
- 235000006533 astragalus Nutrition 0.000 abstract 1
- 230000022534 cell killing Effects 0.000 abstract 1
- 235000005272 common selfheal Nutrition 0.000 abstract 1
- 235000009242 dandelion Nutrition 0.000 abstract 1
- 235000014079 dandelion Nutrition 0.000 abstract 1
- 235000013399 edible fruits Nutrition 0.000 abstract 1
- 239000001947 glycyrrhiza glabra rhizome/root Substances 0.000 abstract 1
- 239000001645 levisticum officinale Substances 0.000 abstract 1
- 235000014063 licorice root Nutrition 0.000 abstract 1
- 235000020636 oyster Nutrition 0.000 abstract 1
- 230000002265 prevention Effects 0.000 abstract 1
- 230000003014 reinforcing Effects 0.000 abstract 1
- 208000002193 Pain Diseases 0.000 description 19
- 230000036407 pain Effects 0.000 description 19
- 210000004072 Lung Anatomy 0.000 description 15
- 210000000481 Breast Anatomy 0.000 description 8
- 210000000038 chest Anatomy 0.000 description 8
- 206010011224 Cough Diseases 0.000 description 7
- 206010062717 Increased upper airway secretion Diseases 0.000 description 7
- 210000000232 Gallbladder Anatomy 0.000 description 6
- 206010019233 Headache Diseases 0.000 description 6
- 210000000214 Mouth Anatomy 0.000 description 6
- 206010037660 Pyrexia Diseases 0.000 description 6
- 210000002784 Stomach Anatomy 0.000 description 6
- 231100000869 headache Toxicity 0.000 description 6
- 230000001737 promoting Effects 0.000 description 6
- 210000001015 Abdomen Anatomy 0.000 description 5
- 206010000087 Abdominal pain upper Diseases 0.000 description 5
- 206010001928 Amenorrhoea Diseases 0.000 description 5
- 208000006820 Arthralgia Diseases 0.000 description 5
- 206010007247 Carbuncle Diseases 0.000 description 5
- 208000002173 Dizziness Diseases 0.000 description 5
- 210000002216 Heart Anatomy 0.000 description 5
- 201000000736 amenorrhea Diseases 0.000 description 5
- 231100000540 amenorrhea Toxicity 0.000 description 5
- 235000013305 food Nutrition 0.000 description 5
- 230000001105 regulatory Effects 0.000 description 5
- 230000002522 swelling Effects 0.000 description 5
- 208000001848 Dysentery Diseases 0.000 description 4
- 206010042674 Swelling Diseases 0.000 description 4
- 235000009508 confectionery Nutrition 0.000 description 4
- 238000003745 diagnosis Methods 0.000 description 4
- 201000010099 disease Diseases 0.000 description 4
- 210000002429 large intestine Anatomy 0.000 description 4
- 231100000486 side effect Toxicity 0.000 description 4
- 230000002269 spontaneous Effects 0.000 description 4
- 238000001356 surgical procedure Methods 0.000 description 4
- 238000002560 therapeutic procedure Methods 0.000 description 4
- 241000208340 Araliaceae Species 0.000 description 3
- 206010018498 Goitre Diseases 0.000 description 3
- 206010023126 Jaundice Diseases 0.000 description 3
- 208000004396 Mastitis Diseases 0.000 description 3
- 206010027514 Metrorrhagia Diseases 0.000 description 3
- 231100000614 Poison Toxicity 0.000 description 3
- 210000004915 Pus Anatomy 0.000 description 3
- 206010040943 Skin ulcer Diseases 0.000 description 3
- 206010068760 Ulcers Diseases 0.000 description 3
- 210000003932 Urinary Bladder Anatomy 0.000 description 3
- 206010047700 Vomiting Diseases 0.000 description 3
- 235000019789 appetite Nutrition 0.000 description 3
- 230000036528 appetite Effects 0.000 description 3
- 230000017531 blood circulation Effects 0.000 description 3
- 230000003419 expectorant Effects 0.000 description 3
- 239000003172 expectorant agent Substances 0.000 description 3
- 201000003872 goiter Diseases 0.000 description 3
- 201000007227 lymph node tuberculosis Diseases 0.000 description 3
- 230000027939 micturition Effects 0.000 description 3
- 230000005180 public health Effects 0.000 description 3
- 231100000397 ulcer Toxicity 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances data:image/svg+xml;base64,PD94bWwgdmVyc2lvbj0nMS4wJyBlbmNvZGluZz0naXNvLTg4NTktMSc/Pgo8c3ZnIHZlcnNpb249JzEuMScgYmFzZVByb2ZpbGU9J2Z1bGwnCiAgICAgICAgICAgICAgeG1sbnM9J2h0dHA6Ly93d3cudzMub3JnLzIwMDAvc3ZnJwogICAgICAgICAgICAgICAgICAgICAgeG1sbnM6cmRraXQ9J2h0dHA6Ly93d3cucmRraXQub3JnL3htbCcKICAgICAgICAgICAgICAgICAgICAgIHhtbG5zOnhsaW5rPSdodHRwOi8vd3d3LnczLm9yZy8xOTk5L3hsaW5rJwogICAgICAgICAgICAgICAgICB4bWw6c3BhY2U9J3ByZXNlcnZlJwp3aWR0aD0nMzAwcHgnIGhlaWdodD0nMzAwcHgnIHZpZXdCb3g9JzAgMCAzMDAgMzAwJz4KPCEtLSBFTkQgT0YgSEVBREVSIC0tPgo8cmVjdCBzdHlsZT0nb3BhY2l0eToxLjA7ZmlsbDojRkZGRkZGO3N0cm9rZTpub25lJyB3aWR0aD0nMzAwLjAnIGhlaWdodD0nMzAwLjAnIHg9JzAuMCcgeT0nMC4wJz4gPC9yZWN0Pgo8dGV4dCB4PScxMDAuNScgeT0nMTcwLjAnIGNsYXNzPSdhdG9tLTAnIHN0eWxlPSdmb250LXNpemU6NDBweDtmb250LXN0eWxlOm5vcm1hbDtmb250LXdlaWdodDpub3JtYWw7ZmlsbC1vcGFjaXR5OjE7c3Ryb2tlOm5vbmU7Zm9udC1mYW1pbHk6c2Fucy1zZXJpZjt0ZXh0LWFuY2hvcjpzdGFydDtmaWxsOiNFODQyMzUnID5IPC90ZXh0Pgo8dGV4dCB4PScxMjYuMScgeT0nMTg2LjAnIGNsYXNzPSdhdG9tLTAnIHN0eWxlPSdmb250LXNpemU6MjZweDtmb250LXN0eWxlOm5vcm1hbDtmb250LXdlaWdodDpub3JtYWw7ZmlsbC1vcGFjaXR5OjE7c3Ryb2tlOm5vbmU7Zm9udC1mYW1pbHk6c2Fucy1zZXJpZjt0ZXh0LWFuY2hvcjpzdGFydDtmaWxsOiNFODQyMzUnID4yPC90ZXh0Pgo8dGV4dCB4PScxMzguMCcgeT0nMTcwLjAnIGNsYXNzPSdhdG9tLTAnIHN0eWxlPSdmb250LXNpemU6NDBweDtmb250LXN0eWxlOm5vcm1hbDtmb250LXdlaWdodDpub3JtYWw7ZmlsbC1vcGFjaXR5OjE7c3Ryb2tlOm5vbmU7Zm9udC1mYW1pbHk6c2Fucy1zZXJpZjt0ZXh0LWFuY2hvcjpzdGFydDtmaWxsOiNFODQyMzUnID5PPC90ZXh0Pgo8L3N2Zz4K data:image/svg+xml;base64,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 O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- 206010000077 Abdominal mass Diseases 0.000 description 2
- 206010003549 Asthenia Diseases 0.000 description 2
- 208000006673 Asthma Diseases 0.000 description 2
- 206010010904 Convulsion Diseases 0.000 description 2
- 241000668709 Dipterocarpus costatus Species 0.000 description 2
- 206010060710 Galactostasis Diseases 0.000 description 2
- 210000003026 Hypopharynx Anatomy 0.000 description 2
- 208000009856 Lung Disease Diseases 0.000 description 2
- 206010027327 Menstrual disease Diseases 0.000 description 2
- 206010027336 Menstruation delayed Diseases 0.000 description 2
- 210000003205 Muscles Anatomy 0.000 description 2
- 206010029410 Night sweats Diseases 0.000 description 2
- 206010068319 Oropharyngeal pain Diseases 0.000 description 2
- 206010067171 Regurgitation Diseases 0.000 description 2
- 210000003491 Skin Anatomy 0.000 description 2
- 239000010839 body fluid Substances 0.000 description 2
- 230000004087 circulation Effects 0.000 description 2
- 230000036461 convulsion Effects 0.000 description 2
- 230000000994 depressed Effects 0.000 description 2
- 239000012530 fluid Substances 0.000 description 2
- 235000019525 fullness Nutrition 0.000 description 2
- 239000012535 impurity Substances 0.000 description 2
- 230000000968 intestinal Effects 0.000 description 2
- 201000003453 lung abscess Diseases 0.000 description 2
- 230000036565 night sweats Effects 0.000 description 2
- 230000003000 nontoxic Effects 0.000 description 2
- 231100000252 nontoxic Toxicity 0.000 description 2
- 230000001717 pathogenic Effects 0.000 description 2
- 230000000144 pharmacologic effect Effects 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 238000007086 side reaction Methods 0.000 description 2
- 231100000019 skin ulcer Toxicity 0.000 description 2
- 230000004936 stimulating Effects 0.000 description 2
- 230000035922 thirst Effects 0.000 description 2
- 239000003440 toxic substance Substances 0.000 description 2
- 208000004998 Abdominal Pain Diseases 0.000 description 1
- 206010063409 Acarodermatitis Diseases 0.000 description 1
- 206010001093 Acute tonsillitis Diseases 0.000 description 1
- 206010002156 Anal fistula Diseases 0.000 description 1
- 208000002894 Beriberi Diseases 0.000 description 1
- 210000001124 Body Fluids Anatomy 0.000 description 1
- 210000000988 Bone and Bones Anatomy 0.000 description 1
- 206010006002 Bone pain Diseases 0.000 description 1
- 208000003643 Callosity Diseases 0.000 description 1
- 241000208365 Celastraceae Species 0.000 description 1
- 206010007882 Cellulitis Diseases 0.000 description 1
- 206010008342 Cervix carcinoma Diseases 0.000 description 1
- 206010008479 Chest pain Diseases 0.000 description 1
- 206010009346 Clonus Diseases 0.000 description 1
- 208000002881 Colic Diseases 0.000 description 1
- 206010010071 Coma Diseases 0.000 description 1
- 206010051625 Conjunctival hyperaemia Diseases 0.000 description 1
- 206010010726 Conjunctival oedema Diseases 0.000 description 1
- 206010010741 Conjunctivitis Diseases 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- 206010012289 Dementia Diseases 0.000 description 1
- 206010012335 Dependence Diseases 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 206010051244 Dyschezia Diseases 0.000 description 1
- 208000005171 Dysmenorrhea Diseases 0.000 description 1
- 206010013935 Dysmenorrhoea Diseases 0.000 description 1
- 210000000981 Epithelium Anatomy 0.000 description 1
- 206010015137 Eructation Diseases 0.000 description 1
- 206010016256 Fatigue Diseases 0.000 description 1
- 206010017553 Furuncle Diseases 0.000 description 1
- 208000000616 Hemoptysis Diseases 0.000 description 1
- 208000005252 Hepatitis A Diseases 0.000 description 1
- 206010019780 Hepatitis infectious Diseases 0.000 description 1
- 206010019909 Hernia Diseases 0.000 description 1
- 239000009636 Huang Qi Substances 0.000 description 1
- 208000008454 Hyperhidrosis Diseases 0.000 description 1
- 206010020649 Hyperkeratosis Diseases 0.000 description 1
- 206010021118 Hypotonia Diseases 0.000 description 1
- 206010022114 Injury Diseases 0.000 description 1
- 210000000936 Intestines Anatomy 0.000 description 1
- 210000003734 Kidney Anatomy 0.000 description 1
- 206010025482 Malaise Diseases 0.000 description 1
- 210000002264 Mammary Glands, Animal Anatomy 0.000 description 1
- 210000004293 Mammary Glands, Human Anatomy 0.000 description 1
- 210000004080 Milk Anatomy 0.000 description 1
- 206010052904 Musculoskeletal stiffness Diseases 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 210000002445 Nipples Anatomy 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 206010033557 Palpitations Diseases 0.000 description 1
- 206010034960 Photophobia Diseases 0.000 description 1
- OXNIZHLAWKMVMX-UHFFFAOYSA-N Picric acid Chemical compound data:image/svg+xml;base64,<?xml version='1.0' encoding='iso-8859-1'?>
<svg version='1.1' baseProfile='full'
              xmlns='http://www.w3.org/2000/svg'
                      xmlns:rdkit='http://www.rdkit.org/xml'
                      xmlns:xlink='http://www.w3.org/1999/xlink'
                  xml:space='preserve'
width='300px' height='300px' viewBox='0 0 300 300'>
<!-- END OF HEADER -->
<rect style='opacity:1.0;fill:#FFFFFF;stroke:none' width='300.0' height='300.0' x='0.0' y='0.0'> </rect>
<path class='bond-0 atom-0 atom-1' d='M 237.8,148.0 L 221.6,148.0' style='fill:none;fill-rule:evenodd;stroke:#E84235;stroke-width:2.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-0 atom-0 atom-1' d='M 221.6,148.0 L 205.4,148.0' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:2.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-1 atom-1 atom-2' d='M 205.4,148.0 L 180.7,190.8' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:2.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-1 atom-1 atom-2' d='M 193.1,149.5 L 175.8,179.5' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:2.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-15 atom-12 atom-1' d='M 180.7,105.2 L 205.4,148.0' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:2.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-2 atom-2 atom-3' d='M 180.7,190.8 L 188.5,204.4' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:2.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-2 atom-2 atom-3' d='M 188.5,204.4 L 196.3,217.9' style='fill:none;fill-rule:evenodd;stroke:#4284F4;stroke-width:2.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-5 atom-2 atom-6' d='M 180.7,190.8 L 131.2,190.8' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:2.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-3 atom-3 atom-4' d='M 194.0,253.3 L 191.7,257.3' style='fill:none;fill-rule:evenodd;stroke:#4284F4;stroke-width:2.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-3 atom-3 atom-4' d='M 191.7,257.3 L 189.4,261.3' style='fill:none;fill-rule:evenodd;stroke:#E84235;stroke-width:2.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-4 atom-3 atom-5' d='M 230.6,238.6 L 234.5,238.6' style='fill:none;fill-rule:evenodd;stroke:#4284F4;stroke-width:2.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-4 atom-3 atom-5' d='M 234.5,238.6 L 238.4,238.6' style='fill:none;fill-rule:evenodd;stroke:#E84235;stroke-width:2.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-4 atom-3 atom-5' d='M 230.6,228.7 L 234.5,228.7' style='fill:none;fill-rule:evenodd;stroke:#4284F4;stroke-width:2.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-4 atom-3 atom-5' d='M 234.5,228.7 L 238.4,228.7' style='fill:none;fill-rule:evenodd;stroke:#E84235;stroke-width:2.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-6 atom-6 atom-7' d='M 131.2,190.8 L 106.5,148.0' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:2.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-6 atom-6 atom-7' d='M 136.1,179.5 L 118.8,149.5' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:2.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-7 atom-7 atom-8' d='M 106.5,148.0 L 94.4,148.0' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:2.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-7 atom-7 atom-8' d='M 94.4,148.0 L 82.3,148.0' style='fill:none;fill-rule:evenodd;stroke:#4284F4;stroke-width:2.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-10 atom-7 atom-11' d='M 106.5,148.0 L 131.2,105.2' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:2.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-8 atom-8 atom-9' d='M 48.0,132.3 L 45.7,128.4' style='fill:none;fill-rule:evenodd;stroke:#4284F4;stroke-width:2.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-8 atom-8 atom-9' d='M 45.7,128.4 L 43.5,124.4' style='fill:none;fill-rule:evenodd;stroke:#E84235;stroke-width:2.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-9 atom-8 atom-10' d='M 41.4,165.2 L 39.1,169.2' style='fill:none;fill-rule:evenodd;stroke:#4284F4;stroke-width:2.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-9 atom-8 atom-10' d='M 39.1,169.2 L 36.8,173.2' style='fill:none;fill-rule:evenodd;stroke:#E84235;stroke-width:2.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-9 atom-8 atom-10' d='M 50.0,170.2 L 47.7,174.2' style='fill:none;fill-rule:evenodd;stroke:#4284F4;stroke-width:2.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-9 atom-8 atom-10' d='M 47.7,174.2 L 45.4,178.1' style='fill:none;fill-rule:evenodd;stroke:#E84235;stroke-width:2.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-11 atom-11 atom-12' d='M 131.2,105.2 L 180.7,105.2' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:2.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-11 atom-11 atom-12' d='M 138.7,115.1 L 173.3,115.1' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:2.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-12 atom-12 atom-13' d='M 180.7,105.2 L 187.4,93.6' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:2.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-12 atom-12 atom-13' d='M 187.4,93.6 L 194.0,82.1' style='fill:none;fill-rule:evenodd;stroke:#4284F4;stroke-width:2.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-13 atom-13 atom-14' d='M 230.6,62.4 L 234.5,62.4' style='fill:none;fill-rule:evenodd;stroke:#4284F4;stroke-width:2.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-13 atom-13 atom-14' d='M 234.5,62.4 L 238.4,62.4' style='fill:none;fill-rule:evenodd;stroke:#E84235;stroke-width:2.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-14 atom-13 atom-15' d='M 200.6,44.2 L 198.3,40.3' style='fill:none;fill-rule:evenodd;stroke:#4284F4;stroke-width:2.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-14 atom-13 atom-15' d='M 198.3,40.3 L 196.1,36.3' style='fill:none;fill-rule:evenodd;stroke:#E84235;stroke-width:2.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-14 atom-13 atom-15' d='M 192.0,49.1 L 189.8,45.2' style='fill:none;fill-rule:evenodd;stroke:#4284F4;stroke-width:2.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-14 atom-13 atom-15' d='M 189.8,45.2 L 187.5,41.3' style='fill:none;fill-rule:evenodd;stroke:#E84235;stroke-width:2.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<text x='248.9' y='157.9' class='atom-0' style='font-size:19px;font-style:normal;font-weight:normal;fill-opacity:1;stroke:none;font-family:sans-serif;text-anchor:start;fill:#E84235' >O</text>
<text x='262.6' y='157.9' class='atom-0' style='font-size:19px;font-style:normal;font-weight:normal;fill-opacity:1;stroke:none;font-family:sans-serif;text-anchor:start;fill:#E84235' >H</text>
<text x='199.5' y='243.5' class='atom-3' style='font-size:19px;font-style:normal;font-weight:normal;fill-opacity:1;stroke:none;font-family:sans-serif;text-anchor:start;fill:#4284F4' >N</text>
<text x='213.1' y='235.6' class='atom-3' style='font-size:13px;font-style:normal;font-weight:normal;fill-opacity:1;stroke:none;font-family:sans-serif;text-anchor:start;fill:#4284F4' >+</text>
<text x='174.8' y='286.4' class='atom-4' style='font-size:19px;font-style:normal;font-weight:normal;fill-opacity:1;stroke:none;font-family:sans-serif;text-anchor:start;fill:#E84235' >O</text>
<text x='188.4' y='278.5' class='atom-4' style='font-size:13px;font-style:normal;font-weight:normal;fill-opacity:1;stroke:none;font-family:sans-serif;text-anchor:start;fill:#E84235' >-</text>
<text x='248.9' y='243.5' class='atom-5' style='font-size:19px;font-style:normal;font-weight:normal;fill-opacity:1;stroke:none;font-family:sans-serif;text-anchor:start;fill:#E84235' >O</text>
<text x='51.1' y='157.9' class='atom-8' style='font-size:19px;font-style:normal;font-weight:normal;fill-opacity:1;stroke:none;font-family:sans-serif;text-anchor:start;fill:#4284F4' >N</text>
<text x='64.8' y='150.0' class='atom-8' style='font-size:13px;font-style:normal;font-weight:normal;fill-opacity:1;stroke:none;font-family:sans-serif;text-anchor:start;fill:#4284F4' >+</text>
<text x='26.4' y='115.1' class='atom-9' style='font-size:19px;font-style:normal;font-weight:normal;fill-opacity:1;stroke:none;font-family:sans-serif;text-anchor:start;fill:#E84235' >O</text>
<text x='40.1' y='107.2' class='atom-9' style='font-size:13px;font-style:normal;font-weight:normal;fill-opacity:1;stroke:none;font-family:sans-serif;text-anchor:start;fill:#E84235' >-</text>
<text x='26.4' y='200.7' class='atom-10' style='font-size:19px;font-style:normal;font-weight:normal;fill-opacity:1;stroke:none;font-family:sans-serif;text-anchor:start;fill:#E84235' >O</text>
<text x='199.5' y='72.3' class='atom-13' style='font-size:19px;font-style:normal;font-weight:normal;fill-opacity:1;stroke:none;font-family:sans-serif;text-anchor:start;fill:#4284F4' >N</text>
<text x='213.1' y='64.4' class='atom-13' style='font-size:13px;font-style:normal;font-weight:normal;fill-opacity:1;stroke:none;font-family:sans-serif;text-anchor:start;fill:#4284F4' >+</text>
<text x='248.9' y='72.3' class='atom-14' style='font-size:19px;font-style:normal;font-weight:normal;fill-opacity:1;stroke:none;font-family:sans-serif;text-anchor:start;fill:#E84235' >O</text>
<text x='262.6' y='64.4' class='atom-14' style='font-size:13px;font-style:normal;font-weight:normal;fill-opacity:1;stroke:none;font-family:sans-serif;text-anchor:start;fill:#E84235' >-</text>
<text x='174.8' y='29.5' class='atom-15' style='font-size:19px;font-style:normal;font-weight:normal;fill-opacity:1;stroke:none;font-family:sans-serif;text-anchor:start;fill:#E84235' >O</text>
</svg>
 data:image/svg+xml;base64,<?xml version='1.0' encoding='iso-8859-1'?>
<svg version='1.1' baseProfile='full'
              xmlns='http://www.w3.org/2000/svg'
                      xmlns:rdkit='http://www.rdkit.org/xml'
                      xmlns:xlink='http://www.w3.org/1999/xlink'
                  xml:space='preserve'
width='85px' height='85px' viewBox='0 0 85 85'>
<!-- END OF HEADER -->
<rect style='opacity:1.0;fill:#FFFFFF;stroke:none' width='85.0' height='85.0' x='0.0' y='0.0'> </rect>
<path class='bond-0 atom-0 atom-1' d='M 69.6,41.4 L 63.6,41.4' style='fill:none;fill-rule:evenodd;stroke:#E84235;stroke-width:1.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-0 atom-0 atom-1' d='M 63.6,41.4 L 57.7,41.4' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:1.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-1 atom-1 atom-2' d='M 57.7,41.4 L 50.7,53.6' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:1.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-1 atom-1 atom-2' d='M 54.2,41.9 L 49.3,50.4' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:1.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-15 atom-12 atom-1' d='M 50.7,29.3 L 57.7,41.4' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:1.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-2 atom-2 atom-3' d='M 50.7,53.6 L 53.6,58.6' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:1.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-2 atom-2 atom-3' d='M 53.6,58.6 L 56.5,63.6' style='fill:none;fill-rule:evenodd;stroke:#4284F4;stroke-width:1.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-5 atom-2 atom-6' d='M 50.7,53.6 L 36.7,53.6' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:1.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-3 atom-3 atom-4' d='M 55.8,69.1 L 53.8,72.4' style='fill:none;fill-rule:evenodd;stroke:#4284F4;stroke-width:1.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-3 atom-3 atom-4' d='M 53.8,72.4 L 51.9,75.8' style='fill:none;fill-rule:evenodd;stroke:#E84235;stroke-width:1.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-4 atom-3 atom-5' d='M 62.3,67.1 L 66.0,67.1' style='fill:none;fill-rule:evenodd;stroke:#4284F4;stroke-width:1.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-4 atom-3 atom-5' d='M 66.0,67.1 L 69.7,67.1' style='fill:none;fill-rule:evenodd;stroke:#E84235;stroke-width:1.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-4 atom-3 atom-5' d='M 62.3,64.3 L 66.0,64.3' style='fill:none;fill-rule:evenodd;stroke:#4284F4;stroke-width:1.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-4 atom-3 atom-5' d='M 66.0,64.3 L 69.7,64.3' style='fill:none;fill-rule:evenodd;stroke:#E84235;stroke-width:1.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-6 atom-6 atom-7' d='M 36.7,53.6 L 29.7,41.4' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:1.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-6 atom-6 atom-7' d='M 38.1,50.4 L 33.2,41.9' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:1.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-7 atom-7 atom-8' d='M 29.7,41.4 L 25.0,41.4' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:1.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-7 atom-7 atom-8' d='M 25.0,41.4 L 20.3,41.4' style='fill:none;fill-rule:evenodd;stroke:#4284F4;stroke-width:1.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-10 atom-7 atom-11' d='M 29.7,41.4 L 36.7,29.3' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:1.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-8 atom-8 atom-9' d='M 14.4,39.3 L 12.5,35.9' style='fill:none;fill-rule:evenodd;stroke:#4284F4;stroke-width:1.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-8 atom-8 atom-9' d='M 12.5,35.9 L 10.6,32.6' style='fill:none;fill-rule:evenodd;stroke:#E84235;stroke-width:1.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-9 atom-8 atom-10' d='M 12.5,44.1 L 10.6,47.5' style='fill:none;fill-rule:evenodd;stroke:#4284F4;stroke-width:1.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-9 atom-8 atom-10' d='M 10.6,47.5 L 8.6,50.8' style='fill:none;fill-rule:evenodd;stroke:#E84235;stroke-width:1.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-9 atom-8 atom-10' d='M 15.0,45.5 L 13.0,48.9' style='fill:none;fill-rule:evenodd;stroke:#4284F4;stroke-width:1.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-9 atom-8 atom-10' d='M 13.0,48.9 L 11.1,52.2' style='fill:none;fill-rule:evenodd;stroke:#E84235;stroke-width:1.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-11 atom-11 atom-12' d='M 36.7,29.3 L 50.7,29.3' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:1.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-11 atom-11 atom-12' d='M 38.8,32.1 L 48.6,32.1' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:1.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-12 atom-12 atom-13' d='M 50.7,29.3 L 53.2,24.9' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:1.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-12 atom-12 atom-13' d='M 53.2,24.9 L 55.8,20.5' style='fill:none;fill-rule:evenodd;stroke:#4284F4;stroke-width:1.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-13 atom-13 atom-14' d='M 62.3,17.2 L 66.0,17.2' style='fill:none;fill-rule:evenodd;stroke:#4284F4;stroke-width:1.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-13 atom-13 atom-14' d='M 66.0,17.2 L 69.7,17.2' style='fill:none;fill-rule:evenodd;stroke:#E84235;stroke-width:1.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-14 atom-13 atom-15' d='M 57.7,14.3 L 55.7,11.0' style='fill:none;fill-rule:evenodd;stroke:#4284F4;stroke-width:1.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-14 atom-13 atom-15' d='M 55.7,11.0 L 53.8,7.6' style='fill:none;fill-rule:evenodd;stroke:#E84235;stroke-width:1.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-14 atom-13 atom-15' d='M 55.2,15.7 L 53.3,12.4' style='fill:none;fill-rule:evenodd;stroke:#4284F4;stroke-width:1.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-14 atom-13 atom-15' d='M 53.3,12.4 L 51.4,9.0' style='fill:none;fill-rule:evenodd;stroke:#E84235;stroke-width:1.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<text x='69.9' y='44.4' class='atom-0' style='font-size:6px;font-style:normal;font-weight:normal;fill-opacity:1;stroke:none;font-family:sans-serif;text-anchor:start;fill:#E84235' >O</text>
<text x='74.0' y='44.4' class='atom-0' style='font-size:6px;font-style:normal;font-weight:normal;fill-opacity:1;stroke:none;font-family:sans-serif;text-anchor:start;fill:#E84235' >H</text>
<text x='55.9' y='68.7' class='atom-3' style='font-size:6px;font-style:normal;font-weight:normal;fill-opacity:1;stroke:none;font-family:sans-serif;text-anchor:start;fill:#4284F4' >N</text>
<text x='60.0' y='66.3' class='atom-3' style='font-size:3px;font-style:normal;font-weight:normal;fill-opacity:1;stroke:none;font-family:sans-serif;text-anchor:start;fill:#4284F4' >+</text>
<text x='48.9' y='80.8' class='atom-4' style='font-size:6px;font-style:normal;font-weight:normal;fill-opacity:1;stroke:none;font-family:sans-serif;text-anchor:start;fill:#E84235' >O</text>
<text x='53.0' y='78.4' class='atom-4' style='font-size:3px;font-style:normal;font-weight:normal;fill-opacity:1;stroke:none;font-family:sans-serif;text-anchor:start;fill:#E84235' >-</text>
<text x='69.9' y='68.7' class='atom-5' style='font-size:6px;font-style:normal;font-weight:normal;fill-opacity:1;stroke:none;font-family:sans-serif;text-anchor:start;fill:#E84235' >O</text>
<text x='13.9' y='44.4' class='atom-8' style='font-size:6px;font-style:normal;font-weight:normal;fill-opacity:1;stroke:none;font-family:sans-serif;text-anchor:start;fill:#4284F4' >N</text>
<text x='18.0' y='42.0' class='atom-8' style='font-size:3px;font-style:normal;font-weight:normal;fill-opacity:1;stroke:none;font-family:sans-serif;text-anchor:start;fill:#4284F4' >+</text>
<text x='6.9' y='32.3' class='atom-9' style='font-size:6px;font-style:normal;font-weight:normal;fill-opacity:1;stroke:none;font-family:sans-serif;text-anchor:start;fill:#E84235' >O</text>
<text x='11.0' y='29.9' class='atom-9' style='font-size:3px;font-style:normal;font-weight:normal;fill-opacity:1;stroke:none;font-family:sans-serif;text-anchor:start;fill:#E84235' >-</text>
<text x='6.9' y='56.6' class='atom-10' style='font-size:6px;font-style:normal;font-weight:normal;fill-opacity:1;stroke:none;font-family:sans-serif;text-anchor:start;fill:#E84235' >O</text>
<text x='55.9' y='20.2' class='atom-13' style='font-size:6px;font-style:normal;font-weight:normal;fill-opacity:1;stroke:none;font-family:sans-serif;text-anchor:start;fill:#4284F4' >N</text>
<text x='60.0' y='17.8' class='atom-13' style='font-size:3px;font-style:normal;font-weight:normal;fill-opacity:1;stroke:none;font-family:sans-serif;text-anchor:start;fill:#4284F4' >+</text>
<text x='69.9' y='20.2' class='atom-14' style='font-size:6px;font-style:normal;font-weight:normal;fill-opacity:1;stroke:none;font-family:sans-serif;text-anchor:start;fill:#E84235' >O</text>
<text x='74.0' y='17.8' class='atom-14' style='font-size:3px;font-style:normal;font-weight:normal;fill-opacity:1;stroke:none;font-family:sans-serif;text-anchor:start;fill:#E84235' >-</text>
<text x='48.9' y='8.0' class='atom-15' style='font-size:6px;font-style:normal;font-weight:normal;fill-opacity:1;stroke:none;font-family:sans-serif;text-anchor:start;fill:#E84235' >O</text>
</svg>
 OC1=C([N+]([O-])=O)C=C([N+]([O-])=O)C=C1[N+]([O-])=O OXNIZHLAWKMVMX-UHFFFAOYSA-N 0.000 description 1
- 208000004880 Polyuria Diseases 0.000 description 1
- 208000003251 Pruritus Diseases 0.000 description 1
- 206010037211 Psychomotor hyperactivity Diseases 0.000 description 1
- 208000008128 Pulmonary Tuberculosis Diseases 0.000 description 1
- 206010072736 Rheumatic disease Diseases 0.000 description 1
- 208000005687 Scabies Diseases 0.000 description 1
- 241000447727 Scabies Species 0.000 description 1
- 206010040872 Skin infection Diseases 0.000 description 1
- 235000000336 Solanum dulcamara Nutrition 0.000 description 1
- 210000004243 Sweat Anatomy 0.000 description 1
- 210000001138 Tears Anatomy 0.000 description 1
- 206010043458 Thirst Diseases 0.000 description 1
- 208000004371 Toothache Diseases 0.000 description 1
- 206010046788 Uterine haemorrhage Diseases 0.000 description 1
- 206010046814 Uterine prolapse Diseases 0.000 description 1
- 206010052769 Vertigos Diseases 0.000 description 1
- 206010047601 Vitamin B1 deficiency Diseases 0.000 description 1
- 206010053692 Wound complication Diseases 0.000 description 1
- 230000003213 activating Effects 0.000 description 1
- 230000001154 acute Effects 0.000 description 1
- 201000004484 acute conjunctivitis Diseases 0.000 description 1
- 230000036592 analgesia Effects 0.000 description 1
- 230000000202 analgesic Effects 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 230000000954 anitussive Effects 0.000 description 1
- 230000001396 anti-anti-diuretic Effects 0.000 description 1
- 230000000844 anti-bacterial Effects 0.000 description 1
- 230000003110 anti-inflammatory Effects 0.000 description 1
- 230000001166 anti-perspirant Effects 0.000 description 1
- 230000001754 anti-pyretic Effects 0.000 description 1
- 230000000840 anti-viral Effects 0.000 description 1
- 239000003213 antiperspirant Substances 0.000 description 1
- 239000002221 antipyretic Substances 0.000 description 1
- 235000019658 bitter taste Nutrition 0.000 description 1
- 201000010881 cervical cancer Diseases 0.000 description 1
- 230000000973 chemotherapeutic Effects 0.000 description 1
- 230000001684 chronic Effects 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 238000002648 combination therapy Methods 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 201000008286 diarrhea Diseases 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000000378 dietary Effects 0.000 description 1
- 238000009792 diffusion process Methods 0.000 description 1
- 230000035619 diuresis Effects 0.000 description 1
- 230000001882 diuretic Effects 0.000 description 1
- 239000002934 diuretic Substances 0.000 description 1
- 238000002651 drug therapy Methods 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 201000006549 dyspepsia Diseases 0.000 description 1
- 239000000262 estrogen Substances 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 230000001815 facial Effects 0.000 description 1
- 230000001605 fetal Effects 0.000 description 1
- 230000002496 gastric Effects 0.000 description 1
- 230000002068 genetic Effects 0.000 description 1
- 230000023597 hemostasis Effects 0.000 description 1
- 238000002649 immunization Methods 0.000 description 1
- 230000003053 immunization Effects 0.000 description 1
- 201000001881 impotence Diseases 0.000 description 1
- 230000037356 lipid metabolism Effects 0.000 description 1
- 201000004792 malaria Diseases 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 230000009245 menopause Effects 0.000 description 1
- 230000002175 menstrual Effects 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 230000000414 obstructive Effects 0.000 description 1
- 201000008125 pain agnosia Diseases 0.000 description 1
- 229940114148 picric acid Drugs 0.000 description 1
- 239000002574 poison Substances 0.000 description 1
- 230000025627 positive regulation of urine volume Effects 0.000 description 1
- 230000002980 postoperative Effects 0.000 description 1
- 230000003389 potentiating Effects 0.000 description 1
- 230000002035 prolonged Effects 0.000 description 1
- 230000002633 protecting Effects 0.000 description 1
- 238000010926 purge Methods 0.000 description 1
- 230000001047 pyretic Effects 0.000 description 1
- 238000001959 radiotherapy Methods 0.000 description 1
- 230000000552 rheumatic Effects 0.000 description 1
- 230000000630 rising Effects 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 230000035807 sensation Effects 0.000 description 1
- 235000019615 sensations Nutrition 0.000 description 1
- 201000009890 sinusitis Diseases 0.000 description 1
- 238000011105 stabilization Methods 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- 230000035900 sweating Effects 0.000 description 1
- 230000001225 therapeutic Effects 0.000 description 1
- 230000017423 tissue regeneration Effects 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 231100000224 toxic side effect Toxicity 0.000 description 1
- 229950002929 trinitrophenol Drugs 0.000 description 1
- 230000004614 tumor growth Effects 0.000 description 1
- 230000036269 ulceration Effects 0.000 description 1
- 210000000689 upper leg Anatomy 0.000 description 1
- 231100000889 vertigo Toxicity 0.000 description 1
- 230000029663 wound healing Effects 0.000 description 1
Abstract
The present invention discloses a breast cancer treatment traditional Chinese medicine, and belongs to the field of traditional Chinese medicines. The breast cancer treatment traditional Chinese medicine is prepared from the following raw materials: 20 g of trichosanthes kirilowii maxim, 20 g of milkvetch root, 20 g of common selfheal spike, 20 g of oyster, 15 g of bupleurum chinense, 15 g of scutellaria baicalensis georgi, 15 g of curcuma aromatica salisb., 15 g of angelica, 15 g of immature tangerine fruit, 15 g of white peony root, 15 g of balloonflower root, 15 g of szechwan lovage rhizome, 10 g of bulbus fritillariae cirrhosae, 10 g of dandelion, 10 g of stiff silkworm, 10 g of ginseng, 10 g of fructus aurantii, 10 g of magnolia officinalis, 10 g of angelica archang lica, 10 g of saposhnikovia divaricata, 10 g of lindera aggregata, 10 g of pangolin, 6 g of tangerine peel, 6 g of akabia stem, and 6 g of licorice root. The breast cancer treatment traditional Chinese medicine has effects of healthy energy supporting, qi reinforcing, blood nourishing, spleen strengthening, liver soothing, blood stasis dissipating, detoxication, good chemotherapy reaction alleviating and cancer recurrence and metastasis prevention so as to increase the comprehensive treatment effect and achieve the purposes of patient symptom improvement and complete cancer cell killing.
Description
Technical field
The present invention relates to a kind of Chinese medicine for the treatment of breast carcinoma, belong to technical field of Chinese medicines.
Background technology
Breast carcinoma refers to the malignant tumor that betides lobules of mammary gland and ductal epithelium, and the sickness rate of breast carcinoma is only second to cervical cancer in China, and crowd's morbidity is 23/,100,000; Account for 7～10% of the various malignant tumor of whole body, so breast carcinoma has become the great public health problem of current social.Early stage mastocarcinoma patient, without any discomfort, only has a smaller lump in breast, and not bitterly, nipple is also unchanged; Breast carcinoma is developed to late period, and surface skin is invaded, and can occur callosity, and very person's skin ulceration forms ulcer.The cause of disease of breast carcinoma still do not understand, how relevant with postmenopausal estrogen with before menopause after deliberation, and separately inherited genetic factors, dietary factor and some breast benign disease and breast carcinoma has certain relation.
Breast carcinoma conventional therapy has at present: 1, operative treatment: after mammary cancer surgery, a lot of patient the dead die from metastasis, and before and after mammary cancer surgery, the strengthening vital QI to eliminate pathogenic factors of Chinese medicine is treated an important especially ring; 2, radiotherapy; 3, medicine chemotherapy; 4, immunization therapy: by transferring internal body system of defense function, reach the effect that stops tumor growth and diffusion.Though above Therapeutic Method has certain effect but curative effect is not good enough.
Summary of the invention
The object of this invention is to provide the Chinese medicine for the treatment of breast carcinoma, this medicine is all selected natural Chinese medicinal herb, can effectively control breast carcinoma.
The technical scheme that technical solution problem of the present invention is taked is: a kind of Chinese medicine for the treatment of breast carcinoma, it is characterized in that, and by the raw material of following weight, made: 20 grams of Fructus Trichosanthis, 20 grams of the Radixs Astragali, 20 grams of Spica Prunellaes, 20 grams of Concha Ostreaes, 15 grams of Radix Bupleuri, 15 grams of Radix Scutellariaes, 15 grams of Radix Curcumaes, 15 grams of Radix Angelicae Sinensis, 15 grams, Pericarpium Citri Reticulatae Viride, 15 grams of the Radix Paeoniae Albas, 15 grams of Radix Platycodoniss, 15 grams of Rhizoma Chuanxiongs, 10 grams of Bulbus Fritillariae Cirrhosaes, 10 grams of Herba Taraxacis, 10 grams of Bombyx Batryticatus, 10 grams of Radix Ginsengs, 10 grams of Fructus Aurantiis, 10 grams of Cortex Magnoliae Officinalis, 10 grams of the Radixs Angelicae Dahuricae, 10 grams of Radix Saposhnikoviaes, 10 grams of the Radixs Linderae, 10 grams of Squama Maniss, 6 grams of Pericarpium Citri Reticulataes, 6 grams of Caulis Akebiaes, 6 grams, Radix Glycyrrhizae.
Preparation and instructions of taking: first by the Impurity removal of each crude drug, all medicines of receiving add 500 milliliters, water in marmite, decoct half an hour, and potion on the one, takes at twice.The breast carcinoma initial stage, or treat after mammary cancer surgery.It within 20 days, is a course for the treatment of.
Pharmacological action:
Fructus Trichosanthis: sweetness and bitterness, cold.Enter lung, stomach, large intestine channel.Lung moistening, reduces phlegm, eliminating stagnation, laxation.Control phlegm-heat cough, the thoracic obstruction, blocked-up chest, consumptive lung disease hemoptysis, quenches one's thirst, jaundice, constipation, carbuncle from the beginning of.
The Radix Astragali: warm in nature, sweet in the mouth.Tonifying Qi and lifting yang, benefit is defended consolidating superficial resistance, promoting pus discharge and tissue regeneration strengthening, diuretic detumescent.Cure mainly weakness of the spleen and stomach, lack of appetite asthenia, deficiency of vital energy blood prostration, exterior deficiency spontaneous perspiration, night sweat.
Spica Prunellae: toil, cold.Enter liver, gallbladder meridian.Liver heat removing, eliminating stagnation.Control scrofula, goiter, acute mastitis, breast carcinoma, order pearl nyctalgia, photophobia is shed tears, the vertigo, facial hemiparalysis, bones and muscles pain, pulmonary tuberculosis, acute icteric infectious hepatitis, metrorrhagia, leukorrhagia.
Concha Ostreae: yin fluid astringing, YANG hyperactivity suppressing, hidroschesis, arresting seminal emission, reduces phlegm, softening the hard mass.Control dizzy, spontaneous perspiration, night sweat, seminal emission, stranguria with turbid discharge, metrorrhagia, leukorrhagia, scrofula, goiter.
Radix Bupleuri: pungent, micro-hardship, be slightly cold; Return liver, gallbladder meridian.Induce sweat and bring down a fever, soothing liver-QI for relieving depression, elevate a turnable ladder yang-energy.This product is dredged and to be reached thoroughly kindly, is longer than and discongests stagnant heat in the liver and gall, again can depressed liver-energy dispersing and QI regulating, and be pain over the hypochondriac region key medicine due to treatment stagnant heat in the liver and gall, stagnation of QI due to depression of the liver.Pharmacological research confirms: the effects such as Radix Bupleuri has stronger antipyretic, antiinflammatory, antibacterial, antiviral, protects the liver, function of gallbladder promoting, calmness, analgesia.
Radix Scutellariae: hardship, cold.Enter the heart, lung, gallbladder, large intestine channel.Removing the relative excess fire, remuval of damp and hot, hemostasis, antiabortive.Control high fever excessive thirst, cough due to lung-heat, damp-heat dysentery, jaundice, pyretic stranguria, tells, is defeated in battle, collapses, leaks, conjunctival congestion and swelling pain, frequent fetal movement, carbuncle furuncle.
Radix Curcumae: arduous, cool.Enter the heart, lung, Liver Channel.Promoting QI circulation for relieving depression, removing heat from blood removing blood stasis with potent drugs, controls all pains of breast abdomen side of body rib, loses the heart demented, and calentura coma, spits blood, jaundice.
Radix Angelicae Sinensis: sweet, acrid, warm.Enter the heart, liver, spleen channel.Benefiting blood and regulating blood circulation, menstruction regulating and pain relieving, moisturizes laxation.Control menoxenia, amenorrhea stomachache ， mass in the abdomen knot is poly-, metrorrhagia; Headache due to deficiency of blood, dizzy, flaccidity syndrome and arthralgia syndrome; Dryness of the intestine dyschezia is heavy after bloody dysentery; Carbuncle skin ulcer is stolen, injury from falling down.
Pericarpium Citri Reticulatae Viride: temperature, acrid in the mouth.Enter liver, gallbladder meridian.Soothing the liver dispelling the stagnated QI, eliminating stagnation expectorant.Control breast side of body gastralgia, hernia, food stagnation, swelling of the breast, nodule in the breast, chronic malaria addiction piece.
The Radix Paeoniae Alba: picric acid is cool.Enter liver, spleen channel.Nourishing blood to suppress the hyperactive liver, slow middle pain relieving, yin fluid astringing is received antiperspirant. control the breast abdomen pain over the hypochondriac region, spontaneous sweating, fever due to yin deficiency.
Radix Platycodonis: toil, flat.Enter lung, stomach warp.Open lung qi dispersing gas, the evacuation of pus of eliminating the phlegm.Control exogenous cough, laryngopharynx swelling and pain, lung abscess vomiting pus, fullness in the chest and hypochondriac pain, dysentery stomachache.
Rhizoma Chuanxiong: acrid in the mouth, temperature.Enter liver, gallbladder meridian.Activating QI to alleviate the depression, method wind-dryness is wet, promoting blood circulation and stopping pain.Control air-cooled headache revolve dizzy, hypochondriac pain abdomen pain, arthralgia due to cold clonic spasm of the muscle, amenorrhea, difficult labour, postpartum stagnation piece pain, ulcer sores.For menoxenia, amenorrhea dysmenorrhea, abdominal mass stomachache, the twinge of the breast side of body, tumbling and swelling, headache, rheumatic arthralgia.
Bulbus Fritillariae Cirrhosae: bitter sweet, cool.Enter lung meridian.Lung moistening eliminating stagnation, antitussive reduces phlegm.Control cough due to consumptive disease, the spitting of blood of spitting, ambition pent-up, consumptive lung disease, lung abscess, goiter, honest and clean scrofula, sore throat, acute mastitis.
Herba Taraxaci: heat-clearing and toxic substances removing, diuresis eliminating stagnation. control acute conjunctivitis, cold, fever, acute tonsillitis.
Bombyx Batryticatus: bring down a fever, cough-relieving, reduces phlegm, calm relieving convulsion, detumescence, and regulate nerve, participate in lipid metabolism.
Radix Ginseng: sweet in the mouth, tepor, nontoxic.Enter spleen, lung meridian.Strongly invigorating primordial QI, promotes the production of body fluid Gu de-, calms the nerves.Control impairment caused by overstrain deficient, lack of appetite, asthenia, food is told in regurgitation, stool lingering diarrhea, empty cough with asthma is short, spontaneous perspiration sudden collapse, palpitation with fear, forgetful, dizziness and headache, sexual impotence, frequent micturition, quenches one's thirst, woman uterine bleeding, children's's intermittent infantile convulsion, and prolonged deficiency is not multiple, the card of all qi-blood-body fluid deficiencies.
Fructus Aurantii: toil, cool.Enter lung, spleen, large intestine channel.Dispelling the stagnated QI, row expectorant, removing food stagnancy.Control chest and diaphragm expectorant stagnant, the feeling of stuffiness in chest, coerce swollen, food stagnation, eructation, vomiting, heavy after dysentery, proctoptosis, uterine prolapse.
Cortex Magnoliae Officinalis: toil, temperature.Enter spleen, stomach, large intestine channel.Have that removing dampness intestinal stasis relieving, circulation of qi promoting are relievingd asthma, wind dispelling analgesic effect.
The Radix Angelicae Dahuricae: pungent, temperature.Enter lung, thigh, stomach warp.Dispel the wind, dampness, detumescence, pain relieving.Control headache, supraorbital bone pain, toothache, nasal sinusitis, cold-damp stomachache, hemorrhoidal hamorrhage anal fistula, leucorrhea with red and white discharge, ulcer sores, skin pruritus due to dryness, scabies.
Radix Saposhnikoviae: Xin Gan, temperature.Enter bladder, lung, spleen channel.Deliver and dispel the wind, victory is wet, pain relieving. control affection of exogenous wind-cold, and headache, dizzy, stiffness of the nape, anemofrigid-damp arthralgia, joint is ached.
The Radix Linderae: acrid in the mouth, temperature, nontoxic.Enter spleen, lung, kidney, urinary bladder channel.Pleasant, dissipating depression of QI, cold expelling, pain relieving.Control QI rising in reverse order chest and abdomen swelling and pain, dyspepsia does not disappear, and food is told in regurgitation, colic of cold type, beriberi, frequent micturition.
Squama Manis: the routed carbuncle of detumescence, search wind active, the stimulating milk secretion of stimulating the menstrual flow.Control carbuncle skin ulcer kind, anemofrigid-damp arthralgia, amenorrhea, galactostasis.
Pericarpium Citri Reticulatae: warm in nature, bitter in the mouth, pungent.Regulating qi-flowing for strengthening spleen, drying dampness to eliminate phlegm.For fullness in the epigastrium and chest, lack of appetite and vomiting, cough ant phlegm.
Caulis Akebiae: hardship, cool.Enter the heart, small intestinal, urinary bladder channel.Pathogenic fire purging row water, promoting blood circulation.Control hot urination, stranguria with turbid discharge, edema, irritable feverish sensation in the chest, sore throat pharyngalgia, inflexible pain all over, women's amenorrhea, galactostasis.
Radix Glycyrrhizae: sweet, flat.GUIXIN, lung, spleen, stomach warp.Invigorating the spleen and replenishing QI, grows and coughs lung moistening, emergency removing toxic substances, mediation hundred medicines.Cure mainly laryngopharynx swelling and pain, cellulitis skin infection, gastrointestinal ulceration and solution poison of drug, alimentary toxicosis etc.
The traditional Chinese medical science thinks, breast carcinoma belongs to the categories such as " newborn painful abdominal mass ", " breast carcinoma " of Chinese medicine, and treatment is with depressed liver-energy dispersing and QI regulating, and it is main letting out clearly liver-fire.
The invention has the beneficial effects as follows: the present invention treats the Chinese medicine of breast carcinoma can strengthening the body resistance, benefiting qi and nourishing blood, invigorating the spleen and relieving depression of liver-QI, dissolving blood stasis and detoxication.Alleviate preferably chemotherapy side effect, can prevent recurrence and the transfer of cancer, to improve patient's combined therapy effect.Reach and improve patient's symptom, thoroughly kill the object of cancerous cell.
Below in conjunction with clinical data and model case, beneficial effect of the present invention is further illustrated.
One, clinical observation
1, clinical data: be selected from the outpatient service of in June, 2011 to 2013 year JIUYUE and inpatient totally 78 examples, wherein breast carcinoma of early stage 24 examples.Age is 34-61 year, average 46.5 years old.
2, diagnostic criteria: the diagnostic criteria of the 8th fascicle < < breast carcinoma > > in the < < China common cancer diagnosis and treatment standard > > that China's Ministry of Public Health of take is compiled is foundation.
3, Therapeutic Method: take medicine of the present invention, decocting boils, takes at twice sooner or later.It within 20 days, is 1 course for the treatment of.
4, efficacy assessment standard: according to breast carcinoma efficacy assessment standard in Ministry of Public Health < < China common cancer diagnosis and treatment standard > >, with before patient treatment with treatment after B ultrasonic or CT compare, alleviating (CR), partial rcsponse (PR), stable (SD) completely, progress (PD) is carried out efficacy evaluation.
5, therapeutic outcome: alleviate 65 examples completely, partial rcsponse 8 examples, stablize 5 examples, progress 0 example.Effective percentage (CR+PR) is 83.3%, and coefficient of stabilization (CR+PR+SD) is 100%.In early stage 24 routine breast carcinoma of early stage, there are 18 examples to cure (tumor all disappears, and follows up a case by regular visits to not recurrence in 1 year) simultaneously.
6, toxic and side effects analysis
In the 78 routine patients that observe, only have 2 routine laxativeness after taking Chinese medicine of the present invention, the probability that occurs side reaction is only 2.6%, through disposing to the ill side reaction, disappears, and all the other are without any side effects.
In sum, the present invention is used for the treatment of the medicine of breast carcinoma, through clinical trial, shows that it can effectively suppress breast cancer development, improves patient's symptom, sign, and without obvious toxic-side effects.
Two, model case
Example one, Jiang Haiyan, 49 years old.Patient was breast carcinoma late period at hospital diagnosis before half a year, then performed the operation, and postoperative wound healing is bad, wound pain, and arm can not lifted.Carried out afterwards chemotherapeutic treatment, because chemotherapy side effect is large, patient can not continual cure.After use Chinese traditional treatment instead, take Drug therapy of the present invention after two courses for the treatment of, chest pain, transference cure uncomfortable in chest, the course for the treatment of of after treatment of continuing to take medicine, existing most symptoms all disappear, physical ability is recovered completely.Follow up a case by regular visits to 1 year, patient lives normally, and the state of an illness has no repeatedly.
Example two, Sun Yating, 35 years old.The existing lump of front left suppurative mastitis half a year, is breast carcinoma of early stage through certain hospital diagnosis, and patient body weakness is not suitable for operative treatment, adopts doctor trained in Western medicine expectant treatment.Two courses for the treatment of of Chinese medicine for the treatment of breast carcinoma through taking this kind, lump progressively diminishes, and continues to take medicine after two courses for the treatment of, and lump disappears completely.Recurrence that so far there are no.
The specific embodiment
Example one: a kind of Chinese medicine for the treatment of breast carcinoma, by the raw material of following weight, made: 20 grams of Fructus Trichosanthis, 20 grams of the Radixs Astragali, 20 grams of Spica Prunellaes, 20 grams of Concha Ostreaes, 15 grams of Radix Bupleuri, 15 grams of Radix Scutellariaes, 15 grams of Radix Curcumaes, 15 grams of Radix Angelicae Sinensis, 15 grams, Pericarpium Citri Reticulatae Viride, 15 grams of the Radix Paeoniae Albas, 15 grams of Radix Platycodoniss, 15 grams of Rhizoma Chuanxiongs, 10 grams of Bulbus Fritillariae Cirrhosaes, 10 grams of Herba Taraxacis, 10 grams of Bombyx Batryticatus, 10 grams of Radix Ginsengs, 10 grams of Fructus Aurantiis, 10 grams of Cortex Magnoliae Officinalis, 10 grams of the Radixs Angelicae Dahuricae, 10 grams of Radix Saposhnikoviaes, 10 grams of the Radixs Linderae, 10 grams of Squama Maniss, 6 grams of Pericarpium Citri Reticulataes, 6 grams of Caulis Akebiaes, 6 grams, Radix Glycyrrhizae.
Preparation and instructions of taking: first by the Impurity removal of each crude drug, all medicines of receiving add 500 milliliters, water in marmite, decoct half an hour, and potion on the one, takes at twice.Breast carcinoma from the beginning of, or treat after mammary cancer surgery.It within 20 days, is a course for the treatment of.
Claims (1)
1. a Chinese medicine for the treatment of breast carcinoma, is characterized in that, by the raw material of following weight, is made:
20 grams of Fructus Trichosanthis, 20 grams of the Radixs Astragali, 20 grams of Spica Prunellaes, 20 grams of Concha Ostreaes, 15 grams of Radix Bupleuri, 15 grams of Radix Scutellariaes, 15 grams of Radix Curcumaes, 15 grams of Radix Angelicae Sinensis, 15 grams, Pericarpium Citri Reticulatae Viride, 15 grams of the Radix Paeoniae Albas, 15 grams of Radix Platycodoniss, 15 grams of Rhizoma Chuanxiongs, 10 grams of Bulbus Fritillariae Cirrhosaes, 10 grams of Herba Taraxacis, 10 grams of Bombyx Batryticatus, 10 grams of Radix Ginsengs, 10 grams of Fructus Aurantiis, 10 grams of Cortex Magnoliae Officinalis, 10 grams of the Radixs Angelicae Dahuricae, 10 grams of Radix Saposhnikoviaes, 10 grams of the Radixs Linderae, 10 grams of Squama Maniss, 6 grams of Pericarpium Citri Reticulataes, 6 grams of Caulis Akebiaes, 6 grams, Radix Glycyrrhizae.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201310677013.8A CN103751702B (en) | 2013-12-12 | 2013-12-12 | A kind of Chinese medicine for the treatment of breast carcinoma |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201310677013.8A CN103751702B (en) | 2013-12-12 | 2013-12-12 | A kind of Chinese medicine for the treatment of breast carcinoma |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN103751702A true CN103751702A (en) | 2014-04-30 |
| CN103751702B CN103751702B (en) | 2016-02-03 |
Family
ID=50519129
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201310677013.8A Expired - Fee Related CN103751702B (en) | 2013-12-12 | 2013-12-12 | A kind of Chinese medicine for the treatment of breast carcinoma |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN103751702B (en) |
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103919984A (en) * | 2014-05-10 | 2014-07-16 | 陈筠 | Traditional Chinese medicine composition for treating mammary gland hyperplasia |
| CN104127818A (en) * | 2014-07-24 | 2014-11-05 | 陈桂风 | Traditional Chinese medicinal preparation for treating breast cancer |
| CN104547863A (en) * | 2014-12-31 | 2015-04-29 | 青岛大学附属医院 | Traditional Chinese medicine preparation for treating breast cancer and preparation method of traditional Chinese medicine preparation |
| CN109893617A (en) * | 2017-12-11 | 2019-06-18 | 曾令元 | A kind of herbal composite that treating breast cancer and preparation method |
Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101085301A (en) * | 2007-06-29 | 2007-12-12 | 胡玉翠 | Oral administration traditional Chinese medicine composition for treating mammary cancer |
| CN101085308A (en) * | 2007-06-29 | 2007-12-12 | 杨文琳 | Oral administration traditional Chinese medicine decoction for treating mammary cancer |
| CN101700393A (en) * | 2009-11-27 | 2010-05-05 | 王芬 | Traditional Chinese medicine composition for treating breast cancer |
| CN102274463A (en) * | 2011-08-01 | 2011-12-14 | 任国祚 | Traditional Chinese medicine capsule for treating breast cancer |
-
2013
- 2013-12-12 CN CN201310677013.8A patent/CN103751702B/en not_active Expired - Fee Related
Patent Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101085301A (en) * | 2007-06-29 | 2007-12-12 | 胡玉翠 | Oral administration traditional Chinese medicine composition for treating mammary cancer |
| CN101085308A (en) * | 2007-06-29 | 2007-12-12 | 杨文琳 | Oral administration traditional Chinese medicine decoction for treating mammary cancer |
| CN101700393A (en) * | 2009-11-27 | 2010-05-05 | 王芬 | Traditional Chinese medicine composition for treating breast cancer |
| CN102274463A (en) * | 2011-08-01 | 2011-12-14 | 任国祚 | Traditional Chinese medicine capsule for treating breast cancer |
Non-Patent Citations (2)
| Title |
|---|
| 房培芹等: ""中药治疗乳腺增生病现状"", 《时珍国医国药》, vol. 11, no. 1, 31 January 2000 (2000-01-31) * |
| 汤鲁霞: ""乳腺癌化疗期间中药治疗的体会"", 《黑龙江中医药》, no. 3, 30 June 2002 (2002-06-30) * |
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103919984A (en) * | 2014-05-10 | 2014-07-16 | 陈筠 | Traditional Chinese medicine composition for treating mammary gland hyperplasia |
| CN104127818A (en) * | 2014-07-24 | 2014-11-05 | 陈桂风 | Traditional Chinese medicinal preparation for treating breast cancer |
| CN104547863A (en) * | 2014-12-31 | 2015-04-29 | 青岛大学附属医院 | Traditional Chinese medicine preparation for treating breast cancer and preparation method of traditional Chinese medicine preparation |
| CN109893617A (en) * | 2017-12-11 | 2019-06-18 | 曾令元 | A kind of herbal composite that treating breast cancer and preparation method |
Also Published As
| Publication number | Publication date |
|---|---|
| CN103751702B (en) | 2016-02-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN103611094B (en) | A kind of medicine for the treatment of cervical cancer | |
| CN100417403C (en) | Traditional Chinese medicine for treating cancer | |
| CN104840904A (en) | Traditional Chinese medicine composition for treating hyperplasia of mammary glands | |
| CN101926961B (en) | Oral Chinese medicinal composition for treating pelvic inflammatory disease | |
| CN103550695B (en) | Medicament for treating breast cancer | |
| CN103550517A (en) | Medicine for treating liver cancer | |
| CN104815292A (en) | Traditional Chinese medicine composition for treating lobular hyperplasia of mammary glands and breast tumor | |
| CN104225479A (en) | Traditional Chinese medicine composition for treating hyperplasia of mammary glands | |
| CN103550696B (en) | Medicine for treating lung cancer | |
| CN103751702B (en) | A kind of Chinese medicine for the treatment of breast carcinoma | |
| CN104399009A (en) | Traditional Chinese medicine formula for treating liver cancer and preparation method adopting traditional Chinese medicine formula | |
| CN104189783A (en) | Traditional Chinese medicine for treating oral ulcer | |
| CN104043057A (en) | Traditional Chinese medicinal composition for treating lymph cancer | |
| CN101607011B (en) | Traditional Chinese medicine for treating cholecystitis post-operative complacation | |
| CN103800842A (en) | Traditional Chinese medicine composition for treating carcinoma of urinary bladder | |
| CN104013925A (en) | Traditional Chinese medicine for treating cervical cancer | |
| CN103977306A (en) | Medicament for treating hepatitis B and preparation method thereof | |
| CN102552753B (en) | Chinese medicinal composition for treating uterine fibroid | |
| CN103656382A (en) | Traditional Chinese medicinal decoction for treating hemorrhoids | |
| CN103736003A (en) | Medicament for treating mammary hyperplasia | |
| CN101708304A (en) | Oral herbal decoction for treating chronic gastritis | |
| CN101618201B (en) | Medicine for curing vulvar leukoplakia | |
| CN101269160A (en) | Chinese medicinal composition for treating trigeminal neuralgia | |
| CN104383464A (en) | Traditional Chinese medicine composition for treating ovarian cancer | |
| CN104352803A (en) | Traditional Chinese medicinal preparation for treating stomach cancer |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| C06 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| C10 | Entry into substantive examination | ||
| GR01 | Patent grant | ||
| CB03 | Change of inventor or designer information |
Inventor after: Han Xinghua Inventor after: Du Xiangping Inventor before: Wang Fen |
|
| TA01 | Transfer of patent application right |
Effective date of registration: 20160113 Address after: 250000, No. 27, Da Nan Road, Licheng District, Shandong, Ji'nan Applicant after: Han Xinghua Applicant after: Du Xiangping Address before: 250355 University Science Park, Changqing District, Shandong, Ji'nan Applicant before: Wang Fen |
|
| COR | Change of bibliographic data | ||
| C14 | Grant of patent or utility model | ||
| C41 | Transfer of patent application or patent right or utility model | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20160203 Termination date: 20161212 |
|
| CF01 | Termination of patent right due to non-payment of annual fee |